<DOC>
	<DOCNO>NCT00293241</DOCNO>
	<brief_summary>The purpose study demonstrate benefit MVP pacemaker implantable cardioverter defibrillator ( ICD ) patient history right ventricular pacing .</brief_summary>
	<brief_title>PreFER Managed Ventricular Pacing ( MVP ) For Elective Replacement</brief_title>
	<detailed_description>A number clinical study ( Danish I , Danish II , David , MOST ) past year show , patient intact atrioventricular ( AV ) conduction , unnecessary chronic right ventricular ( RV ) pacing cause variety detrimental effect , include atrial fibrillation ( AF ) , leave ventricular ( LV ) dysfunction , congestive heart failure ( CHF ) . These effect believe result mechanical dyssynchrony ventricular chamber dysfunction occur chronic , single-site , apical ventricular stimulation . Therefore new pace modality , Managed Ventricular Pacing ( MVP ) , design give preference natural heart activity minimize unnecessary right ventricular pacing . This accomplish automatically switch single chamber atrial dual-chamber pacing base specific patient need . MVP atrial-based dual-chamber pacing mode provide functional AAI/R pace ventricular monitoring back-up DDD/R pacing need episode AV block . The reversibility detrimental effect cause ventricular pacing initially investigate small patient population short pace duration AAI need investigation .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Patients implant dual chamber device ( include atrial synchronous ventricular inhibit [ VDD ] ) minimum time duration 2 year Planned replace replaced device include MVP feature Have 40 % ventricular pacing document old device period least 4 week enrollment device replacement . Pacing caused switch single chamber pacing ( VVI ) mode battery depletion Have sign inform consent Have need change pace mode atrioventricular ( AV ) interval . Patients cardiac resynchronization therapy ( CRT ) indication Permanent AF Permanent AV block Inability complete followup visit study center . Unwillingness inability cooperate give write informed consent , patient minor , legal guardian refuse give inform consent Planned cardiovascular intervention Inclusion another clinical trial affect objective study Neurocardiogenic syncope primary implantable pulse generator ( IPG ) indication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Pacemaker ICD replacement</keyword>
</DOC>